Jabil (JBL) ·

Jabil Stock Rebounds to $258.89 Amid Institutional Buying and Valuation Debate

Jabil Inc. shares gained 3.6% on November 11 to reach $258.89. The climb follows strong quarterly results and expanded institutional stakes despite questions about intrinsic valuation.

Trading terminal with market data screens

Jabil Inc. shares increased 3.6% on November 11, 2026, closing at $258.89. Over the past 52 weeks, the stock has traded between $189.60 and $428.93. The recent uptick follows a volatile stretch, including a 5.6% advance on November 9 to $252.56 and a 4.8% drop on November 4 to $258.56.

The climb comes alongside heightened institutional buying during the third quarter. According to a regulatory filing, Allspring Global Investments Holdings LLC increased its position in Jabil by 101.6%, purchasing 178,433 shares to hold 354,043 shares valued at roughly $106,139,000. Other firms, including StoneX Group Inc. and Pictet Asset Management Holding SA, also added to their holdings. Overall, institutional investors own 93.39% of the company's stock.

In operational results reported for its prior quarter, Jabil posted earnings per share of $4.40, exceeding the $4.05 consensus expectation. Revenue climbed 28.6% year over year to $10.62 billion, topping the $9.69 billion projected by analysts. Net margin reached 2.90%, while return on equity stood at 89.50%. For the first quarter of 2027, the company issued earnings guidance of 3.800 to 4.200 per share, with full-year 2027 earnings guided at 17.550 per share. Jabil also declared an $0.08 quarterly dividend payable on December 2.

Despite positive earnings, valuation assessments present mixed signals. According to GuruFocus, the stock's $258.89 price on November 11 stood 3.7% above its proprietary GF Value estimate of $249.69, labeling the stock as fairly valued but lacking a margin of safety. Jabil's trailing price-to-earnings ratio of 26.5x remains well above its five-year median of 14.8x. GuruFocus also pointed to substantial insider selling over the past 12 months, with $57.9 million in sales against $0.1 million in purchases.

Wall Street research desks retain an optimistic outlook. MarketBeat reported an overall consensus rating of Buy and an average price target of $437.22. Brokerages including JPMorgan Chase & Co., UBS Group, and The Goldman Sachs Group recently set or raised price targets between $397.00 and $430.00, while Bank of America boosted its objective to $475.00.